Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SS)
CNY 63.1
(1.25%)
CNY 63.1
(1.25%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 62.94 Million CNY | 96.27% |
| 2022 | 32.07 Million CNY | 54.22% |
| 2021 | 20.79 Million CNY | 92.87% |
| 2020 | 10.78 Million CNY | 4176.62% |
| 2019 | 252.13 Thousand CNY | 505.66% |
| 2018 | 41.63 Thousand CNY | 29.8% |
| 2017 | 32.07 Thousand CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 38.8 Million CNY | -0.99% |
| 2024 Q2 | 39.19 Million CNY | -15.02% |
| 2024 Q1 | 46.12 Million CNY | -26.73% |
| 2023 Q4 | 62.94 Million CNY | 4.58% |
| 2023 FY | 62.94 Million CNY | 96.27% |
| 2023 Q3 | 60.19 Million CNY | 6.16% |
| 2023 Q1 | 40.84 Million CNY | 27.35% |
| 2023 Q2 | 56.69 Million CNY | 38.81% |
| 2022 Q2 | 24.26 Million CNY | 11.03% |
| 2022 Q1 | 21.85 Million CNY | 5.08% |
| 2022 Q4 | 32.07 Million CNY | 36.62% |
| 2022 FY | 32.07 Million CNY | 54.22% |
| 2022 Q3 | 23.47 Million CNY | -3.25% |
| 2021 Q2 | 18.37 Million CNY | 28.25% |
| 2021 Q3 | 22.25 Million CNY | 21.1% |
| 2021 FY | 20.79 Million CNY | 92.87% |
| 2021 Q1 | 14.33 Million CNY | 32.9% |
| 2021 Q4 | 20.79 Million CNY | -6.56% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 FY | 10.78 Million CNY | 4176.62% |
| 2020 Q4 | 10.78 Million CNY | 1558.43% |
| 2020 Q3 | 650.18 Thousand CNY | 188.19% |
| 2020 Q2 | 225.6 Thousand CNY | 0.0% |
| 2019 FY | 252.13 Thousand CNY | 505.66% |
| 2019 Q4 | 252.13 Thousand CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 FY | 41.63 Thousand CNY | 29.8% |
| 2017 FY | 32.07 Thousand CNY | 0.0% |